期刊
JOURNAL OF IMMUNOLOGY
卷 176, 期 3, 页码 1305-1310出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.176.3.1305
关键词
-
类别
资金
- NIAID NIH HHS [R01 AI31105] Funding Source: Medline
- NIAMS NIH HHS [R01 AR051749] Funding Source: Medline
- NIDDK NIH HHS [K08 DK064790-02] Funding Source: Medline
The complement system is increasingly recognized as important in the pathogenesis of tissue injury in vivo following immune, ischemic, or infectious insults. Within the complement system, three pathways are capable of initiating the processes that result in C3 activation: classical alternative, and lectin. Although the roles that proinflammatory peptides and complexes generated during complement activation play in mediating disease processes have been studied extensively, the relative contributions of the three activating pathways is less well understood. Herein we examine recent evidence that the alternative complement pathway plays a key and, in most instances, obligate role in generating proinflammatory complement activation Products in vivo. In addition, we discuss new concepts regarding the mechanisms by which the alternative pathway is activated in vivo, as recent clinical findings and experimental results have provided evidence that continuous active control of this pathway is necessary to prevent unintended targeting and injury to self tissues. The Journal of Immunology, 2006.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据